Is it necessary to measure basal serum lipid levels in cancer patients prior to tamoxifen treatment?

Creative Commons License

Sütcüoğlu O., Yazıcı O., Özet A.

Future oncology (London, England), vol.17, pp.4823-4825, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Editorial Material
  • Volume: 17
  • Publication Date: 2021
  • Doi Number: 10.2217/fon-2021-1107
  • Journal Name: Future oncology (London, England)
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Page Numbers: pp.4823-4825
  • Keywords: breast cancer, hormonal therapy, hypertriglyceridemia, side effects, tamoxifen, RANDOMIZED-TRIAL, INDUCED HYPERTRIGLYCERIDEMIA, ACUTE-PANCREATITIS, BREAST, WOMEN, PROLIFERATION, THERAPY, MARKERS
  • Gazi University Affiliated: Yes